# 2026-19540: DEA Greenlights Another Pot Importer—Comments Welcome!

2026-19540, Importer of Controlled Substances Application: Fisher Clinical Services, Inc. (I), is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2026-09-24, effective Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before October 26, 2026. Such persons may also file a written request for a hearing on the application on or before October 26, 2026.; PRIA reads it as touching household money (as of 2026-10-01).

- Canonical: https://policyrisk.com/federal-register/2026-19540
- As of: 2026-10-01
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-19540
- Title: Importer of Controlled Substances Application: Fisher Clinical Services, Inc. (I)
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 60655
- Published: 2026-09-24
- Effective: Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before October 26, 2026. Such persons may also file a written request for a hearing on the application on or before October 26, 2026.
- Comments close: 2026-10-26
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-10-01

## In one line

DEA Greenlights Another Pot Importer—Comments Welcome!

## Summary

Fisher Clinical Services, Inc. wants to become an official importer of certain controlled substances like marijuana and its extracts. This affects companies involved in drug manufacturing and importation, who can comment or request a hearing by October 26, 2026. No direct costs are mentioned, but this move could impact how these substances enter the U.S. market.

## Abstract

Fisher Clinical Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

## Effects PRIA read

- Importer Application for Schedule I/II Drugs: benefit, low. On August 13, 2026, Fisher Clinical Services, Inc. applied to be registered to import specific controlled substances. The list includes Schedule I codes (Marihuana Extract 7350; Marihuana 7360; Tetrahydrocannabinols 7370; 3,4‑Methylenedioxy‑methamphetamine 7405; 5‑Methoxy‑N‑N‑Dimethyltryptamine 743…
- No Import of Finished Dosage Forms: cost, low. The DEA notice states that approval will not authorize the import of Food and Drug Administration‑approved or non‑approved finished dosage forms for commercial sale. The registration is limited to the listed drug codes and to imports for clinical trials; no other activities for these codes are auth…

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-20749](https://policyrisk.com/federal-register/2026-20749): Vladimir Romaniv, P.A.; Decision and Order, 2026-10-09
- [2026-20750](https://policyrisk.com/federal-register/2026-20750): L Krenk DBA Maui Clinic Pharmacy; Decision and Order, 2026-10-09

## Sources
- [2026-19540 on federalregister.gov](https://www.federalregister.gov/documents/2026/09/24/2026-19540/importer-of-controlled-substances-application-fisher-clinical-services-inc-i)
- [2026-19540 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-09-24/pdf/2026-19540.pdf)

## Related
- [Previous: 2026-19539, Importer of Controlled Substances Application: Cambridge Isotope Laboratories,…](https://policyrisk.com/federal-register/2026-19539)
- [Next: 2026-19541, Bulk Manufacturer of Controlled Substances Application: Eli-Elsohly Laboratories](https://policyrisk.com/federal-register/2026-19541)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-19540 (as of 2026-10-01).